On March 15, 2023 OncoNano Medicine, Inc. reported three poster presentations at the American Association for Cancer Research (AACR) (Free AACR Whitepaper) Annual Meeting 2023, taking place April 14-19, 2023 at the Orange County Convention Center, Orlando, Florida (Press release, OncoNano Medicine, MAR 15, 2023, View Source [SID1234628853]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Presentation Overview:
TITLE:
Improved tolerability and tumor specific delivery of a therapeutic bispecific T cell engager using a pH-sensitive nanoparticle platform
PRESENTER:
Qingtai Su, Ph.D.
DATE:
April 16, 2023
TIME:
1:30 – 5:00 PM ET
SECTION and PRESENTATION NUMBER:
Poster Section 30, No. 815
TITLE:
Encapsulation of IL-12 with an ultra pH-sensitive nanoparticle platform improves tolerability and promotes antitumor response in mice
PRESENTER:
Tian Zhao, Ph.D.
DATE:
April 16, 2023
TIME:
1:30 – 5:00 PM ET
SECTION and PRESENTATION NUMBER:
Poster Section 34, No. LB001
TITLE:
ONM-501, a dual-activating polyvalent STING agonist, enhances tumor retention and demonstrates favorable preclinical safety profile
PRESENTER:
Zirong Chen, Ph.D.
DATE:
April 18, 2023
TIME:
1:30 – 5:00 PM ET
SECTION and PRESENTATION NUMBER:
Poster Section 34, No. LB245